NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10

NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10

Abstract Prostate cancer (PCa) is one of the most common male genitourinary system malignancies. Despite the significant benefits of anti-PD-L1 immune checkpoint inhibitor therapy in other cancers, the reasons for its poor therapeutic efficacy in prostate cancer (PCa) remain unclear.NDR1 plays an im...

全面介紹

書目詳細資料
Main Authors: Meiling Fu, Jinxin Li, Zuodong Xuan, Zeyuan Zheng, Yankuo Liu, Zeyi Zhang, Jianzhong Zheng, Min Zhong, Bin Liu, Yifan Du, Lei Zhang, Huimin Sun
格式: Article
語言:English
出版: BMC 2024-09-01
叢編:Cell Communication and Signaling
主題:
Prostate cancer
NDR1/STK38, PD-L1
Immune escape
Immune checkpoint Blockade
Anti-PD-1 therapy
在線閱讀:https://doi.org/10.1186/s12964-024-01805-5

因特網

https://doi.org/10.1186/s12964-024-01805-5

相似書籍